Back to search

Article

Efficacy and safety of belimumab in immune thrombocytopenia secondary to systemic lupus erythematosus

2025-09-08

Abstract excerpt

<title>Abstract</title> <p>Objective We aimed to investigate the safety and effectiveness of belimumab for patients with refractory immune thrombocytopenia (ITP) secondary to systemic lupus erythematosus (SLE) Method This is a multi-centre, retrospective cohort study. Data from patients with SLE–ITP received belimumab in addition to basic drug therapy between January 2017 and January 2025 were retrospectively ana...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4576cf72-2835-5d21-85c0-cd48c97f9931
DOI
10.21203/rs.3.rs-7238587/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy and safety of belimumab in immune thrombocytopenia secondary to systemic lupus erythematosusDOI 10.21203/rs.3.rs-7238587/v1
Select a neighboring publication to make it the new centre.